Search results
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 6 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 6 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Intra-Cellular depression drug succeeds in second late-stage study
BioPharma Dive via Yahoo Finance· 7 days agoThe results position the company to unlock what’s believed to be a multibillion-dollar sales...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 5 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
Slow recovery for life science
San Mateo Daily Journal· 12 hours agoStiffening regulation, government shortfalls and long-term leasing trends are contributing to the life science industry’s sluggish recovery, marked by...
5 Undervalued Stocks From Morningstar’s New LGBTQ+ Index
Morningstar· 5 days agoDEI is a cornerstone of the “social” pillar of environmental, social, and governance investing,...
Gateway - Quartz
Quartz· 7 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
Chutes & Ladders—Third Rock's cardiometabolic biotech unveils C-suite
FierceBiotech· 4 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
M&A Is Back. 4 Stocks That Could Be Targets.
Barrons.com· 6 days agoMergers are back—and that means opportunity for small-cap investors. The return of M&A has been helped along by a number of factors, including a...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
New York Times· 4 days agoPharmacy benefit managers are driving up drug costs for millions of people, employers and the...
